Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00732628 · ClinicalTrials.gov registry record
Evaluating Outcomes in the Placement of Boomerang Percutaneous Device
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00732628: Clinical Trial study, sponsored by University of Michigan.
NCT00732628 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00732628 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Boomerang percutaneous closure device following diagnostic cerebral angiography or neurointerventional procedures. Background: Very few publications have evaluated this relatively novel percutaneous closure device.
Interventions
- DEVICE Boomerang closure device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-09 |
Why NCT00732628 stopped before completion
NCT00732628 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Boomerang closure device is the first listed.
NCT00732628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00732628 about?
NCT00732628 is a clinical study titled "Evaluating Outcomes in the Placement of Boomerang Percutaneous Device". The purpose of this study is to evaluate the safety and effectiveness of the Boomerang percutaneous closure device following diagnostic cerebral angiography or neurointerventional procedures. Background: Very few publications have evaluated this relatively novel percutaneous closure device.
What is the current status of trial NCT00732628?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2008-01. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00732628?
The interventions under investigation include: Boomerang closure device (DEVICE).
Who is sponsoring clinical trial NCT00732628?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia